Covid-19 e Pós-pandemia: Implicações e impactos em pacientes com doenças cardiovasculares
DOI:
https://doi.org/10.34119/bjhrv6n1-233Keywords:
Covid-19, pandemia, doenças cardiovascularesAbstract
A COVID-19 desencadeou uma série de mudanças nos dados epidemiológicos de diversas patologias, uma vez que é um fator agravante em diversas doenças, destacando-se as doenças cardiacas As complicações consideradas em pacientes com COVID-19 possui diversos mecanismos, desde injuria cardiaca direta, ou por lesão cardiaca indireta pelo virus, como a resposta inflamatoria, lesão endotelial e problemas de coagulação gerados pelo patogeno. O acompanhamento de pacientes com esse tipo de condição cardiaca é de grande importancia, pois, um manejo terapeutico eficiente e cauteloso pode minimizar as sequelas deixadas por essa manifestação viral.
References
Armstrong ADC, Santos LG, Leal TC, Paiva JPS, Silva LFD, Santana GBA, Rocha CAO, Feitosa TA, Araújo SLM, Bezerra-Santos M, Souza CDF, Carmo RFD. In-Hospital Mortality from Cardiovascular Diseases in Brazil during the First Year of The COVID-19 Pandemic. Arq Bras Cardiol. 2022 Jul;119(1):37-45
Bansal, M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(3), 247-250.
Del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020 Nov 3;324(17):1723-1724.
Ghisi GLM, Santos RZ, Korbes AS, Souza CA, Karsten M, Oh P, Benetti M. Perceptions of Cardiac Rehabilitation Participants Regarding their Health Behaviors and Information Needs during the COVID-19 Pandemic in Brazil. Arq Bras Cardiol. 2022 May;118(5):949-960.
Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, et al. COVID-19 and Cardiac Arrhythmias: A Global Perspective on Arrhythmia Characteristics and Management Strategies. J Interv Card Electrophysiol. 2020;59(2):329-36
Melo ACNF, Saraiva GS, Alencar MC, Pereira WA, Figueiredo AQ, de Souza Filho JB, Albano ACPB, Sales MA. Análise dos casos de COVID-19 em uma cidade no sertão da Paraíba: Analysis of COVID-19 cases in a city in the sertão of Paraíba. Brazilian Journal of Development, 8(11), 74998–75014.
Nascimento JHP, Costa RLD, Simvoulidis LFN, Pinho JC, Pereira RS, Porto AD, Silva ECF, Oliveira LP, Ramos MRF, Oliveira GMM. COVID-19 and Myocardial Injury in a Brazilian ICU: High Incidence and Higher Risk of In-Hospital Mortality. Arq Bras Cardiol. 2021 Feb;116(2):275-282.
Oldridge N, Taylor RS. Cost-effectiveness of exercise therapy in patients with coronary heart disease, chronic heart failure and associated risk factors: A systematic review of economic evaluations of randomized clinical trials. Eur J Prev Cardiol. 2020 Jul;27(10):1045-1055
Queiroz JVVG, Chumpato LP, Junior JP, Carrijo FO, Oliveira MC. “Complicações cardíacas pós infecção por COVID-19: Cardiac complications post COVID-19 infection”, Brazilian Journal of Development, 8(11), pp. 71434–71440.
Saeed, S., Tadic, M., Larsen, T. H., Grassi, G., & Mancia, G. (2021). Coronavirus disease 2019 and cardiovascular complications: focused clinical review. Journal of Hypertension, 39(7), 1282-1292.
Soeiro AM. How Can the Presence of Cardiovascular Diseases Impact Morbidity and Mortality in Patients with COVID-19? Arq Bras Cardiol. 2022 May;118(5):935-936.
Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022 May;10(5):311-321.
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nature medicine. 2022 Feb; 28(3), 583-590.
